thorenco medical isotopes llc
Thorenco will be the premier supplier of scarce isotopes used as active pharmaceutical ingredients in new, more effective cancer drugs.
New cancer drugs depend on a reliable supply of isotopes that are now in short supply. Using its proprietary production technology, Thorenco will manufacture isotopes used in new drugs that treat prostate cancer and other cancers that spread to bone. These isotopes can be used to treat primary tumors as well. There will be no isotope shortage for new cancer drugs after Thorenco becomes part of the global supply chain.